Latest Blog Posts Tagged "Netherlands"
December 21, 2018
Several trials recently took steps forward to advance new therapies that could slow or stop Parkinson's progression and treat movement and non-movement symptoms.
August 20, 2018
Five clinical trials are recruiting volunteers to test new treatments for non-motor symptoms associated with Parkinson's disease.
August 02, 2018
Denali will move its drug into trials with patients with or without a LRRK2 mutation after new research points to potential widespread use of these therapies.
July 17, 2018
A promising approach to stopping Parkinson's is to target the rogue protein alpha-synuclein. We share the latest on six trials testing therapies with this goal.
June 04, 2018
A drug trial for people with a genetic form of Parkinson's disease (PD) is recruiting volunteers at more than 30 sites around the world.
February 28, 2017
Jazz Pharmaceuticals recently announced a Phase II trial to test a therapy for excessive daytime sleepiness in people with Parkinson's disease.
October 20, 2016
Members of the MJFF Patient Council will participate in a pilot to develop and test a method to integrate patient preferences on benefits and risks into trials.
September 01, 2016
MJFF-funded trial evaluating a novel therapy to treat Parkinson's disease dementia is actively recruiting.
August 24, 2016
To keep you informed of the Foundation's research investments, we're highlighting a few newly funded grants supporting the development of therapies to address common non-motor symptoms of Parkinson's.
December 28, 2015
In this blog, we highlight research progress in 2015 and look forward to accomplishments in 2016.